Muller & Phipps (India) Limited (BOM:501477)

India · Delayed Price · Currency is INR

209.10

-10.25 (-4.67%)

At close: Aug 24, 2026

-21.93% (1Y)

Market Cap	131.19M -21.6%
Revenue (ttm)	67.05M +1.0%
Net Income	-6.30M
EPS	-10.08
Shares Out	625.00K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14
Open	210.00
Previous Close	219.35
Day's Range	209.00 - 210.00
52-Week Range	188.10 - 275.70
Beta	-0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Muller & Phipps (India)

Muller & Phipps (India) Limited markets and distributes over the counter medical preparation and home care products in India. The company sells medicated dental cream, gel, and gum astringent products under the Cavisan brand; skincare products under the Cavidine and Nixoderm brand name; cosmetics and toiletries, medicated preparations, and food products. It markets its products through a network of chemists, general stores, provisional/kirana stores, and supermarkets. The company was incorporated in 1917 and is headquartered in Mumbai, India. T... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1917

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 501477

Full Company Profile

Financial Performance

In fiscal year 2026, Muller & Phipps (India)'s revenue was 69.08 million, an increase of 11.51% compared to the previous year's 61.94 million. Losses were -475,000, -93.72% less than in 2025.

Financial Statements